Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Cardiovascular Outcome Data Tirzepatide has the SURMOUNT-MMO trial underway, with results expected in 2026 that will directly measure cardiovascular event reduction
What safeguards are in place to monitor patient outcomes
Business Type Manufacturer, Supplier, Trading Company Employee Count 10 Establishment 2019 Working Days To GST NO 06ABCCS8001K1ZE Payment Mode Cash Advance (CA) Related Products Explore Related Categories More Products From This Seller Seller Details GST - 06ABCCS8001K1ZE Yamunanagar, Haryana Proprietor Mr
Starting low and gradually increasing it will help to reduce the possibility of adverse effects
US$ 20.25
US$ 29.45
US$ 23.82
US$ 27.40
